Company announcements: SG MEDICAL

SG MEDICAL - ANNOUNCEMENT OF CESSATION AS INDEPENDENT DIRECTOR

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: SINGAPORE MEDICAL GROUP LTD
Stock Code/Name: 5OT - SG MEDICAL

ANNOUNCEMENT OF CESSATION AS INDEPENDENT DIRECTOR * Asterisks denote mandatory information Name of Announcer * SINGAPORE MEDICAL GROUP LTD Company Registration No. 200503187W Announcement submitted on behalf of SINGAPORE MEDICAL GROUP LTD Announcement is submitted with respect to * SINGAPORE MEDICAL GROUP LTD Announcement is submitted by * Tay Chee Wah Designation * Company Secretary Date & Time of Broadcast 02-Dec-2013 21:16:20 Announcement No. 00159   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Name of person * Lew Foon Keong, Charles Age * 56 Is Effective Date of Cessation known? * Yes If yes, please provide the date * 02/12/2013 Detailed Reason(s) for cessation * Due to the change in majority shareholders upon the completion of the Voluntary Conditional Cash Offer, the board has been reduced in size. Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No If yes, please elaborate * NA Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No If yes, please elaborate * NA Any other relevant information to be provided to shareholders of the listed issuer? * No If yes, please elaborate * NA Date of Appointment to current position * 22/06/2009 Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Independent Director, Chairman of Nominating Committee, Chairman of Remenuration Committee and member of Audit Committee. Role and responsibilities * Fulfilling duties and responsibilities as an Independent Director and Chairman of Nominating Committee and Remuneration Committee and a member of Audit Committee. Does the AC have a minimum of 3 members (taking into account this cessation)? * Yes Number of Independent Directors currently resident in Singapore (taking into account this cessation) * Two Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months * 4, including cessation of Felix Huang Keming, Dr Xiaoyan Baumann Geb. Bi, Mrs See-Toh Wai Keong nee Ng Kwee Lang and Lew Foon Keong, Charles. Interest * in the listed issuer and its subsidiaries * N/A Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * No   >> OTHER DIRECTORSHIPS Past (for the last 5 years) * Dayadina Kiara Point Sdn Bhd RHB Private Equity Management Ltd Present * Equator Capital Private Limited Muddy Murphy Holdings Private Limited (formally known as Gaelic Inns Pte Ltd) The Penny Black Pte Ltd Scruffy Murphys Pte Ltd Durty Nelly's Pte Ltd Othellos Cafe Bar Pte Ltd LFE Estates Pte Ltd RHB Islamic Bank Bhd RHB Investment Bank Bhd Dayadina Nusa Jaya Sdn Bhd Nusa Utama Sdn Bhd Equator Capital Ventures Ltd Equator Star Holdings Ltd Wykeham International Ltd Aroma Seroja Sdn Bhd Mega Grand Sdn Bhd Chalstar Management Sdn Bhd Dayadina Sdn Bhd Hogweil Sdn Bhd Footnotes This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor (the "Sponsor"), Asian Corporate Advisors Pte. Ltd., for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement, including the correctness of any of the figures used, statements or opinions made. The Sponsor is satisfied, based on the enquiries made, that there are no reasons for the resignation other than those stated in this announcement. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr. Liau H.K. Telephone number: 6221 0271 Attachments Total size = 0K (2048K size limit recommended)

---

SG MEDICAL - ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: SINGAPORE MEDICAL GROUP LTD
Stock Code/Name: 5OT - SG MEDICAL

ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR * Asterisks denote mandatory information Name of Announcer * SINGAPORE MEDICAL GROUP LTD Company Registration No. 200503187W Announcement submitted on behalf of SINGAPORE MEDICAL GROUP LTD Announcement is submitted with respect to * SINGAPORE MEDICAL GROUP LTD Announcement is submitted by * Tay Chee Wah Designation * Company Secretary Date & Time of Broadcast 02-Dec-2013 21:08:31 Announcement No. 00158   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Name of person * Mrs. See-Toh Wai Keong nee Ng Kwee Lang Age * 56 Is Effective Date of Cessation known? * Yes If yes, please provide the date * 02/12/2013 Detailed Reason(s) for cessation * Following the close of Voluntary Conditional Cash Offer Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No If yes, please elaborate * NA Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No If yes, please elaborate * NA Any other relevant information to be provided to shareholders of the listed issuer? * No If yes, please elaborate * NA Date of Appointment to current position * 22/06/2009 Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Executive Director Role and responsibilities * Advising the Group on issues of compliance, corporate governance, corporate citizenship and social responsibility. Does the AC have a minimum of 3 members (taking into account this cessation)? * Yes Number of Independent Directors currently resident in Singapore (taking into account this cessation) * Two Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months * 4, including cessation of Felix Huang Keming, Dr Xiaoyan Baumann Geb. Bi, Mrs See-Toh Wai Keong nee Ng Kwee Lang and Lew Foon Keong, Charles. Shareholding * in the listed issuer and its subsidiaries * 38,000 ordinary share of the listed issuer Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * Sister of Felix Huang Keming and sister-in-law of Dr. Xiaoyan Baumann Geb. Bi. Both Felix Huang Keming and Dr. Xiaoyan Geb. Bi have ceased as directors with effect from 2 December 2013.   >> OTHER DIRECTORSHIPS Past (for the last 5 years) * None Present * None Footnotes This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor (the "Sponsor"), Asian Corporate Advisors Pte. Ltd., for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement, including the correctness of any of the figures used, statements or opinions made. The Sponsor is satisfied, based on the enquiries made, that there are no reasons for the resignation other than those stated in this announcement. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr. Liau H.K. Telephone number: 6221 0271 Attachments Total size = 0K (2048K size limit recommended)

---

SG MEDICAL - ANNOUNCEMENT OF CESSATION AS CHIEF EXECUTIVE OFFICER

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: SINGAPORE MEDICAL GROUP LTD
Stock Code/Name: 5OT - SG MEDICAL

ANNOUNCEMENT OF CESSATION AS CHIEF EXECUTIVE OFFICER * Asterisks denote mandatory information Name of Announcer * SINGAPORE MEDICAL GROUP LTD Company Registration No. 200503187W Announcement submitted on behalf of SINGAPORE MEDICAL GROUP LTD Announcement is submitted with respect to * SINGAPORE MEDICAL GROUP LTD Announcement is submitted by * Tay Chee Wah Designation * Company Secretary Date & Time of Broadcast 02-Dec-2013 21:07:00 Announcement No. 00157   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Name of person * Dr. Xiaoyan Baumann Geb. Bi Age * 45 Is Effective Date of Cessation known? * Yes If yes, please provide the date * 02/12/2013 Detailed Reason(s) for cessation * Following the close of the Voluntary Conditional Cash Offer Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No If yes, please elaborate * NA Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No If yes, please elaborate * NA Any other relevant information to be provided to shareholders of the listed issuer? * No If yes, please elaborate * NA Date of Appointment to current position * 07/11/2005 Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Chief Executive Officer Role and responsibilities * Responsible for the overall management of the Groups businesses and operations. Does the AC have a minimum of 3 members (taking into account this cessation)? * Yes Number of Independent Directors currently resident in Singapore (taking into account this cessation) * Two Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months * 4, including cessation of Felix Huang Keming, Dr Xiaoyan Baumann Geb. Bi, Mrs See-Toh Wai Keong nee Ng Kwee Lang and Lew Foon Keong, Charles. Shareholding * in the listed issuer and its subsidiaries * 14,573,700 Shares of the Listed issuer, representing 10% of the issued and paid up capital of the Listed issuer Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * Dr Xiaoyan Baumann Geb. Bi. is the wife of Mr Felix Huang Keming and sister-in-law of Mrs. See-Toh Wai Keong nee Ng Kwee Lang.   >> OTHER DIRECTORSHIPS Past (for the last 5 years) * Singapore Aesthetic Centre Pte Ltd Singapore Eye & Cornea Transplant Centre Pte. Ltd. Present * Singapore Vision Centre Pte Ltd Cancer Centre Pte Ltd Singapore Aesthetic Centre Pte Ltd The Dental Studio Pte Ltd The Lasik Surgery Clinic Pte Ltd Singapore Lipo, Body & Face Centre Pte Ltd Singapore Sports Orthopaedic Surgery Pte Ltd SMG International Partners Pte Ltd Premium Lasik Surgery Cetre Pte Ltd Centre for Heart & Lung Surgery Pte Ltd The Obstetrics & Gynaecology Centre Pte Ltd Centre for Eye Surgery Pte Ltd TOGC@Parkway East Hospital Pte Ltd Centre for Joint & Cartilage Surgery Pte Ltd Centre for Spine & Scoliosis Surgery Pte Ltd SMG Orthopeadic Group Pte Ltd Centre for Wellness & Healthy Aging Pte Ltd SMG Neuro Science Centre Pte Ltd Zhong Ji Shi Jia Co. Ltd Footnotes This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor (the "Sponsor"), Asian Corporate Advisors Pte. Ltd., for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement, including the correctness of any of the figures used, statements or opinions made. The Sponsor is satisfied, based on the enquiries made, that there are no reasons for the resignation other than those stated in this announcement. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr. Liau H.K. Telephone number: 6221 0271 Attachments Total size = 0K (2048K size limit recommended)

---

SG MEDICAL - ANNOUNCEMENT OF CESSATION AS EXECUTIVE CHAIRMAN

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: SINGAPORE MEDICAL GROUP LTD
Stock Code/Name: 5OT - SG MEDICAL

ANNOUNCEMENT OF CESSATION AS EXECUTIVE CHAIRMAN * Asterisks denote mandatory information Name of Announcer * SINGAPORE MEDICAL GROUP LTD Company Registration No. 200503187W Announcement submitted on behalf of SINGAPORE MEDICAL GROUP LTD Announcement is submitted with respect to * SINGAPORE MEDICAL GROUP LTD Announcement is submitted by * Tay Chee Wah Designation * Company Secretary Date & Time of Broadcast 02-Dec-2013 21:05:42 Announcement No. 00155   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Name of person * Felix Huang Keming Age * 60 Is Effective Date of Cessation known? * Yes If yes, please provide the date * 02/12/2013 Detailed Reason(s) for cessation * Following the close of the Voluntary Conditional Cash Offer Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No If yes, please elaborate * NA Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No If yes, please elaborate * NA Any other relevant information to be provided to shareholders of the listed issuer? * No If yes, please elaborate * NA Date of Appointment to current position * 22/06/2009 Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Executive Chairman Role and responsibilities * Charting the corporate direction and business strategies, policy planning and overall management of our Group. Does the AC have a minimum of 3 members (taking into account this cessation)? * Yes Number of Independent Directors currently resident in Singapore (taking into account this cessation) * Two Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months * 4, including cessation of Felix Huang Keming, Dr Xiaoyan Baumann Geb. Bi, Mrs See-Toh Wai Keong nee Ng Kwee Lang and Lew Foon Keong, Charles. Shareholding * in the listed issuer and its subsidiaries * 4,000 ordinary share of the listed issuer Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * Felix Huang Keming is the husband of Dr Xiaoyan Baumann Geb. Bi and brother of Mrs. See-Toh Wai Keong nee Ng Kwee Lang. Both Dr Xiaoyan Baumann Geb. Bi and Mrs. See-Toh Wai Keong nee Ng Kwee Lang have ceased as directors with effect from 2 December 2013.   >> OTHER DIRECTORSHIPS Past (for the last 5 years) * N.A. Present * Premium Lasik Surgery Centre Pte Ltd Centre for Heart & Lung Surgery Pte Ltd The Obstetrics & Gynaecology Centre Pte Ltd Singapore Eye & Cornea Transplant Centre Pte Ltd Centre for Eye Surgery Pte Ltd TOGC@Parkway East Hospital Pte Ltd Centre for Joint & Cartilage Surgery Pte Ltd Centre for Spine & Scoliosis Surgery Pte Ltd SMG Orthopedic Group Pte Ltd Centre for Wellness & Healthy Aging Pte Ltd SMG Neuro Science Centre Pte Ltd Singapore Medical Group Limited Singapore Medical Group (HK) Ltd Zhong Ji Shi Jia Co., Ltd Footnotes This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor (the "Sponsor"), Asian Corporate Advisors Pte. Ltd., for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement, including the correctness of any of the figures used, statements or opinions made. The Sponsor is satisfied, based on the enquiries made, that there are no reasons for the resignation other than those stated in this announcement. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr. Liau H.K. Telephone number: 6221 0271 Attachments Total size = 0K (2048K size limit recommended)

---

SG MEDICAL - ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: SINGAPORE MEDICAL GROUP LTD
Stock Code/Name: 5OT - SG MEDICAL

ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER * Asterisks denote mandatory information Name of Announcer * SINGAPORE MEDICAL GROUP LTD Company Registration No. 200503187W Announcement submitted on behalf of SINGAPORE MEDICAL GROUP LTD Announcement is submitted with respect to * SINGAPORE MEDICAL GROUP LTD Announcement is submitted by * Tay Chee Wah Designation * Company Secretary Date & Time of Broadcast 02-Dec-2013 21:01:46 Announcement No. 00154   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Date of Appointment * 02/12/2013 Name of person * Dr Beng Teck Liang (Meng Deliang) Age * 42 Country of principal residence * Singapore The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * The appointment of Dr Beng as an executive Director and Chief Executive Officer was recommended by the Nominating Committee and approved by the Board, after taking into consideration Dr Bengs qualifications and experience. Whether appointment is executive, and if so, the area of responsibility * Appointment is executive. Dr Beng will be responsible for the overall management of the Groups businesses and operations. Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Executive Director and Chief Executive Officer Working experience and occupation(s) during the past 10 years * Dr Beng has vast experience in the information technology and healthcare sectors across Asia Pacific and Japan. He was in Hewlett Packard for approximately 8 years in a variety of senior leadership roles including most recently as Managing Director for Hewlett Packard, Thailand and General Manager for Hewlett Packards Enterprise Services segment across South East Asia. In 2007, Dr Beng helped to found the Singapore Chapter of Operation Smile, a worldwide charitable organization that works to repair childhood facial deformities including cleft palates, remaining on its board until the end of 2010. Dr Beng served in Tampines East Constituency as an executive committee member and in the PAP Policy Forum as an elected member of the executive committee previously. Interest * in the listed issuer and its subsidiaries * Direct interest in the ordinary shares of the listed issuer of 20.427% Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * N/A Conflict of interests (including any competing business) * N/A   >> OTHER DIRECTORSHIP # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8). Past (for the last 5 years) CCFH Ltd (formerly known as Friven & Co Ltd) Singapore Chapter of Operation Smile Ltd Minemydna Pte. Ltd. Present BB Ventures Pte Ltd   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H) Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given. (a)* Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No (b)* Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No (c)* Whether there is any unsatisfied judgment against him? No (d)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No (e)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No (f)* Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No (g)* Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No (h)* Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No (i)* Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No (j)* Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- (i)* any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No (ii)* any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No (iii)* any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No (iv)* any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No (k)* Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(I) Disclosure applicable to the appointment of Director only. Any prior experience as a director of a listed company? Yes If yes, please provide details of prior experience. CCFH Ltd (formerly known as Friven & Co Ltd) Footnotes This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor (the "Sponsor"), Asian Corporate Advisors Pte. Ltd., for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "Exchange"). The Sponsor has not independently verified the contents of this announcement, including the correctness of any of the figures used, statements or opinions made. This announcement has not been examined or approved by the Exchange and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr. Liau H.K. Telephone number: 6221 0271 Attachments Total size = 0K (2048K size limit recommended)

---